Johannes Karges develops anti-cancer agents that work in a targeted manner, rather than adversely affecting the entire body.
What to watch for as Stryker, Boston Scientific and BD post earnings this week
The medtech earnings season continues this week with all eyes on whether Stryker, Boston Scientific and BD can add to the evidence of strong fundamentals